IL6 and familial pancreatic carcinoma: Furthermore, pro-inflammatory markers, such as IL-6, IL-8, IL-10, and IL-1 receptor antagonist, are elevated in the serum of patients with pancreatic cancer, with IL-6 specifically being an indicator of poor prognosis [87].